Tirosint 75 mcg/1ml oral solution

Tirosint is a pharmaceutical product containing levothyroxine sodium, used primarily for the treatment of hypothyroidism. It is notably recognized for its innovative liquid and softgel delivery systems, which are formulated without various common excipients like alcohol, sugar, and gluten to enhance absorption and tolerability.

The brand is owned by IBSA (Institut Biochimique SA), a Swiss multinational pharmaceutical company headquartered in Lugano. While IBSA has a significant presence in Italy through its major subsidiary, IBSA Farmaceutici Italia S.r.l. (which handles distribution and local marketing), the core manufacturing of Tirosint is conducted in specialized, dedicated facilities in Switzerland (specifically Manno and Lugano) to ensure high quality standards and prevent cross-contamination.